Sartorius Stedim Biotech S.A. (EPA: DIM)
France
· Delayed Price · Currency is EUR 184.00
+0.30 (0.16%)
Aug 30, 2024, 5:35 PM CET
Sartorius Stedim Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,065 | 937 | 716 | 404.3 | 88.8 | 624.9 | Upgrade
|
| Loss (Gain) From Sale of Investments | 198 | 318 | -310 | 0.4 | -34.7 | -415.6 | Upgrade
|
| Loss (Gain) on Equity Investments | -119 | -123 | -128 | -104.9 | -110.5 | -129.8 | Upgrade
|
| Other Operating Activities | 687 | 710 | 971 | 500.9 | 575.4 | 841.4 | Upgrade
|
| Change in Accounts Receivable | -251 | -251 | - | - | - | - | Upgrade
|
| Change in Inventory | -129 | -129 | - | - | - | - | Upgrade
|
| Change in Income Taxes | -60 | -60 | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 321 | 522 | -143 | 236.2 | 103.2 | 105.3 | Upgrade
|
| Operating Cash Flow | 4,902 | 5,005 | 4,148 | 3,147 | 2,725 | 3,088 | Upgrade
|
| Operating Cash Flow Growth | 4.46% | 20.66% | 31.80% | 15.49% | -11.75% | 8.71% | Upgrade
|
| Capital Expenditures | -3,120 | -3,140 | -2,784 | -1,729 | -1,609 | -1,676 | Upgrade
|
| Sale of Property, Plant & Equipment | 297 | 318 | 598 | 316.4 | 235.9 | 162.8 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -1,473 | - | Upgrade
|
| Divestitures | - | - | - | - | 91 | - | Upgrade
|
| Investment in Securities | -122 | 414 | 5,999 | 227.7 | -3,417 | 1,187 | Upgrade
|
| Investing Cash Flow | -2,840 | -2,124 | 4,524 | -850.6 | -6,140 | -255.3 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | 1,084 | - | Upgrade
|
| Long-Term Debt Issued | - | 970 | 879 | 931.4 | 4,302 | 1,824 | Upgrade
|
| Total Debt Issued | 1,737 | 970 | 879 | 931.4 | 5,385 | 1,824 | Upgrade
|
| Short-Term Debt Repaid | - | -948 | -4,138 | -38.6 | - | -465 | Upgrade
|
| Long-Term Debt Repaid | - | -1,200 | -2,333 | -629.7 | -690 | -1,403 | Upgrade
|
| Total Debt Repaid | -1,801 | -2,148 | -6,471 | -668.3 | -690 | -1,868 | Upgrade
|
| Net Debt Issued (Repaid) | -64 | -1,178 | -5,592 | 263.1 | 4,695 | -43.3 | Upgrade
|
| Issuance of Common Stock | 263 | 269 | 227 | 3,190 | 147.2 | 17.9 | Upgrade
|
| Repurchase of Common Stock | -213 | - | -505 | - | -8.3 | - | Upgrade
|
| Common Dividends Paid | -977 | -877 | -775 | -420.9 | -277.1 | -509.1 | Upgrade
|
| Other Financing Activities | -1,231 | -1,353 | -3,525 | -737.4 | -1,037 | -1,094 | Upgrade
|
| Financing Cash Flow | -2,222 | -3,139 | -10,170 | 2,295 | 3,520 | -1,628 | Upgrade
|
| Foreign Exchange Rate Adjustments | -179 | -228 | 46 | 63.2 | -25.7 | -3.9 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 4 | -26 | - | 1.8 | - | Upgrade
|
| Net Cash Flow | -339 | -482 | -1,478 | 4,654 | 81.3 | 1,200 | Upgrade
|
| Free Cash Flow | 1,782 | 1,865 | 1,364 | 1,418 | 1,116 | 1,412 | Upgrade
|
| Free Cash Flow Growth | 1.02% | 36.73% | -3.84% | 27.05% | -20.92% | 4.07% | Upgrade
|
| Free Cash Flow Margin | 3.98% | 4.11% | 3.18% | 4.98% | 4.29% | 5.19% | Upgrade
|
| Free Cash Flow Per Share | 2.41 | 2.55 | 1.91 | 2.30 | 1.93 | 2.44 | Upgrade
|
| Cash Interest Paid | 775 | 681 | 770 | 462.1 | 516.8 | 549.6 | Upgrade
|
| Cash Income Tax Paid | 561 | 637 | 557 | 285.6 | 258.3 | 241.8 | Upgrade
|
| Levered Free Cash Flow | 532.45 | 2,041 | 2,616 | 2,274 | 488.19 | 1,904 | Upgrade
|
| Unlevered Free Cash Flow | 1,114 | 2,522 | 3,004 | 2,520 | 765.31 | 2,198 | Upgrade
|
| Change in Net Working Capital | 840.3 | -740 | -1,068 | -1,201 | 253.4 | -853.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.